Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Olema Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 185
- −8 vs. Q1 2026
- Shares held
- 101.9M
- +7.57M (+8.0%) vs. Q1 2026
- Total value
- $1.28B
- −$131.9M (−9.4%) vs. Q1 2026
- New holders
- 25
- 74 more added
- Sold out
- 33
- 60 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −38,000−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −21,247−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −16,710−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −16,443−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −15,773−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −15,301−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −14,633−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −11,127−100.0% | Sold out |
| Conway Capital Management, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −1,164−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −721−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Activest Wealth Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |